SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950149-05-000081
Filing Date
2005-03-18
Accepted
2005-03-18 15:25:09
Documents
9
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K f06191e10vk.htm 10-K 782982
2 EXHIBIT 10.18 f06191exv10w18.htm EX-10.18 8319
3 EXHIBIT 21.1 f06191exv21w1.htm EX-21.1 1610
4 EXHIBIT 23.1 f06191exv23w1.htm EX-23.1 2166
5 EXHIBIT 31.1 f06191exv31w1.htm EX-31.1 8842
6 EXHIBIT 31.2 f06191exv31w2.htm EX-31.2 8948
7 EXHIBIT 32.1 f06191exv32w1.htm EX-32.1 3395
8 EXHIBIT 32.2 f06191exv32w2.htm EX-32.2 3500
9 GRAPHIC f06191f0619100.gif GRAPHIC 11653
  Complete submission text file 0000950149-05-000081.txt   833873
Mailing Address 9500 GILMAN DR UNIVERSITY OF CALIFORNIA LA JOLLA CA 92093-0663
Business Address 717 POTTER STREET, SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE
Type: 10-K | Act: 34 | File No.: 000-50577 | Film No.: 05691566
SIC: 2834 Pharmaceutical Preparations